Cargando…

Osteosarcoma-enriched transcripts paradoxically generate osteosarcoma-suppressing extracellular proteins

Osteosarcoma (OS) is the common primary bone cancer that affects mostly children and young adults. To augment the standard-of-care chemotherapy, we examined the possibility of protein-based therapy using mesenchymal stem cells (MSCs)-derived proteomes and OS-elevated proteins. While a conditioned me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Kexin, Huo, Qingji, Dimmitt, Nathan H, Qu, Guofan, Bao, Junjie, Pandya, Pankita H, Saadatzadeh, M Reza, Bijangi-Vishehsaraei, Khadijeh, Kacena, Melissa A, Pollok, Karen E, Lin, Chien-Chi, Li, Bai-Yan, Yokota, Hiroki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	eLife Sciences Publications, Ltd 2023
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030111/ https://www.ncbi.nlm.nih.gov/pubmed/36943734 http://dx.doi.org/10.7554/eLife.83768

Ejemplares similares

Suppression of osteosarcoma progression by engineered lymphocyte-derived proteomes
por: Li, Kexin, et al.
Publicado: (2022)

The Role of MDM2 in Promoting Genome Stability versus Instability
por: Saadatzadeh, M. Reza, et al.
Publicado: (2017)

Precision Medicine Highlights Dysregulation of the CDK4/6 Cell Cycle Regulatory Pathway in Pediatric, Adolescents and Young Adult Sarcomas
por: Barghi, Farinaz, et al.
Publicado: (2022)

Emerging targets for glioblastoma stem cell therapy
por: Safa, Ahmad R., et al.
Publicado: (2016)

Glioblastoma stem cells (GSCs) epigenetic plasticity and interconversion between differentiated non-GSCs and GSCs
por: Safa, Ahmad R., et al.
Publicado: (2015)

c-FLIP, a Novel Biomarker for Cancer Prognosis, Immunosuppression, Alzheimer’s Disease, Chronic Obstructive Pulmonary Disease (COPD), and a Rationale Therapeutic Target
por: Safa, Ahmad R, et al.
Publicado: (2019)

Systems Biology Approach Identifies Prognostic Signatures of Poor Overall Survival and Guides the Prioritization of Novel BET-CHK1 Combination Therapy for Osteosarcoma
por: Pandya, Pankita H., et al.
Publicado: (2020)

Glycogen synthase kinase 3β promotes osteosarcoma invasion and migration via regulating PTEN and phosphorylation of focal adhesion kinase
por: Mai, Wei, et al.
Publicado: (2021)

Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma
por: Cheng, Lijun, et al.
Publicado: (2019)

PLK2 phosphorylates and inhibits enriched TAp73 in human osteosarcoma cells
por: Hu, Zheng Bo, et al.
Publicado: (2015)

PLK2 modulation of enriched TAp73 affects osteogenic differentiation and prognosis in human osteosarcoma
por: Li, Wenhu, et al.
Publicado: (2020)

Micro-RNA 122 and micro-RNA 96 affected human osteosarcoma biological behavior and associated with prognosis of patients with osteosarcoma
por: Liu, Bin, et al.
Publicado: (2020)

CXCR3 from chemokine receptor family correlates with immune infiltration and predicts poor survival in osteosarcoma
por: Tang, Yin, et al.
Publicado: (2019)

Establishment and characterization of patient-derived xenograft of a rare pediatric anaplastic pleomorphic xanthoastrocytoma (PXA) bearing a CDC42SE2-BRAF fusion
por: Damayanti, Nur P., et al.
Publicado: (2023)

The regulatory effect of has-circ-0001146/miR-26a-5p/MNAT1 network on the proliferation and invasion of osteosarcoma
por: Wang, Junjie, et al.
Publicado: (2020)

Relationship between red cell distribution width and prognosis of patients with osteosarcoma
por: Zheng, Jian, et al.
Publicado: (2019)

SMARCB1 expression is a novel diagnostic and prognostic biomarker for osteosarcoma
por: Guo, Tao, et al.
Publicado: (2022)

The Double-Edged Proteins in Cancer Proteomes and the Generation of Induced Tumor-Suppressing Cells (iTSCs)
por: Li, Kexin, et al.
Publicado: (2023)

Three unconventional maxims in the natural selection of cancer cells: Generation of induced tumor-suppressing cells (iTSCs)
por: Li, Kexin, et al.
Publicado: (2023)

Variability in the reported management of pulmonary metastases in osteosarcoma
por: Bhattasali, Onita, et al.
Publicado: (2015)

Hsa_circ_0003732 promotes osteosarcoma cells proliferation via miR-545/CCNA2 axis
por: Li, Li, et al.
Publicado: (2020)

Enrichment of osteosarcoma stem cells by chemotherapy
por: Tang, Qing-Lian, et al.
Publicado: (2011)

Long non-coding RNA TUSC7 suppresses osteosarcoma by targeting miR-211
por: Cong, Menglin, et al.
Publicado: (2019)

Targeting Podoplanin for the Treatment of Osteosarcoma
por: Takemoto, Ai, et al.
Publicado: (2022)

Overcoming cisplatin resistance in osteosarcoma through the miR-199a-modulated inhibition of HIF-1α
por: Keremu, Ajimu, et al.
Publicado: (2019)

HDAC6 inhibitor WT161 performs anti-tumor effect on osteosarcoma and synergistically interacts with 5-FU
por: Sun, Jun, et al.
Publicado: (2021)

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
por: Palmini, Gaia, et al.
Publicado: (2016)

Reassessment of alkaline phosphatase as serum tumor marker with high specificity in osteosarcoma
por: Kim, Seung Hyun, et al.
Publicado: (2017)

A comparison of risk factors for metastasis at diagnosis in humans and dogs with osteosarcoma
por: Diessner, Brandon J., et al.
Publicado: (2019)

The Immune System in Cancer Pathogenesis: Potential Therapeutic Approaches
por: Pandya, Pankita H., et al.
Publicado: (2016)

Identification of Biomarkers for Osteosarcoma Based on Integration Strategy
por: Bao, Junjie, et al.
Publicado: (2020)

Signature based on metabolic‐related gene pairs can predict overall survival of osteosarcoma patients
por: Li, Long‐Qing, et al.
Publicado: (2021)

Hybrid liposomes inhibit tumor growth and lung metastasis of murine osteosarcoma cells
por: Kitajima, Hideki, et al.
Publicado: (2013)

Inhibition of the activin receptor signaling pathway: A novel intervention against osteosarcoma
por: Meier, Daniela, et al.
Publicado: (2020)

Subclonal Somatic Copy-Number Alterations Emerge and Dominate in Recurrent Osteosarcoma
por: Kinnaman, Michael D., et al.
Publicado: (2023)

A Retrospective Clinicopathological Study of Osteosarcoma Patients with Metachronous Metastatic Relapse
por: Bao, Junjie, et al.
Publicado: (2019)

Integrative Multi-OMICs Identifies Therapeutic Response Biomarkers and Confirms Fidelity of Clinically Annotated, Serially Passaged Patient-Derived Xenografts Established from Primary and Metastatic Pediatric and AYA Solid Tumors
por: Pandya, Pankita H., et al.
Publicado: (2022)

Exosome‐transmitted linc00852 associated with receptor tyrosine kinase AXL dysregulates the proliferation and invasion of osteosarcoma
por: Li, Qiming, et al.
Publicado: (2020)

CBX2 is a functional target of miRNA let‐7a and acts as a tumor promoter in osteosarcoma
por: Han, Qicai, et al.
Publicado: (2019)

m6A-dependent up-regulation of DRG1 by METTL3 and ELAVL1 promotes growth, migration, and colony formation in osteosarcoma
por: Ling, Zhian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l87950ij5ce5dksuvo23gkjuiv